Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men

Autor: Mwajuma Chemba, Vicente Urbano, Anita Manoj, Carl Maas, Diosdado N. Milang, Tobias Schindler, Peter F. Billingsley, B. Kim Lee Sim, Marcel Tanner, Minglin Li, Oscar M. Embon, Matthew Adams, Elizabeth Nyakarungu, Matilde Riloha Rivas, Esther Eburi, Stephen L. Hoffman, Martin Eka, Mitoha Ondo’o Ayekaba, Claudia Daubenberger, J. Luis Segura, Sumana Chakravarty, Eric R. James, Ali Hamad, Salim Abdulla, Adam Ruben, Natasha Kc, Jose Raso, Dolores Mbang Ondo Mandumbi, Christopher Schwabe, Thomas L. Richie, Ally Olotu, Tooba Murshedkar, Elizabeth Saverino, Dianna Hergott, Yonas Abebe

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
The American Journal of Tropical Medicine and Hygiene

Equatorial Guinea (EG) has implemented a successful malaria control program on Bioko Island. A highly effective vaccine would be an ideal complement to this effort and could lead to halting transmission and eliminating malaria. Sanaria® PfSPZ Vaccin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1ca2804a1969887cad0963152c82f31
https://doi.org/10.4269/ajtmh.17-0449